More
    Guided Solutions - Connecting Talent With Innovation/div>

    Lucida Medical raises £8.7M to power ‘same day’ cancer diagnosis

    IW Capital has invested in Lucida Medical, a UK-based healthtech company using AI to help clinicians diagnose prostate cancer from MRI scans faster and more accurately. The £8.7m funding round includes participation from existing...

    Lucida Medical raises £8.7M to power ‘same day’ cancer diagnosis

    IW Capital has invested in Lucida Medical, a UK-based healthtech company using AI to help clinicians diagnose prostate cancer from MRI scans faster and...

    Data supports Boston Scientific Watchman FLX in stroke reduction

    Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system. Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...

    Medtronic wins CE mark for OmniaSecure pacemaker lead

    Medtronic announced CE mark approval and the first commercial European implants for its OmniaSecure system. The OmniaSecure defibrillation lead connects to an implantable defibrillator. It...

    Anumana secures FDA clearance for ECG-AI algorithm

    Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Data supports Boston Scientific Watchman FLX in stroke reduction

    Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system. Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...

    iPerf enrolls first patient in study of dual-flow femoral artery cannula

    iPerf announced the first-in-human use of its new dual-flow femoral arterial cannula device. Lyon, France-based iPerf designed its device to integrate an additional flow...

    Providence Medical enrols first patients in CORUS-LX system trial

    Providence Medical Technology has enrolled the first subjects in its prospective, randomised controlled trial (RCT) assessing the CORUS-LX system to treat degenerative lumbosacral disease. The...

    Senseonics reports sustained year-long CGM implant outcomes

    Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM. Real-world evidence demonstrated the long-term performance and positive...

    Innovation

    Regulatory Approvals

    Lucida Medical raises £8.7M to power ‘same day’ cancer diagnosis

    IW Capital has invested in Lucida Medical, a UK-based healthtech company using AI to help clinicians diagnose prostate cancer from MRI scans faster and...

    Data supports Boston Scientific Watchman FLX in stroke reduction

    Boston Scientific announced new findings from the CHAMPION-AF trial supporting its Watchman FLX system. Watchman FLX, Boston Scientific’s left atrial appendage closure (LAAC) device, reduces...

    Medtronic wins CE mark for OmniaSecure pacemaker lead

    Medtronic announced CE mark approval and the first commercial European implants for its OmniaSecure system. The OmniaSecure defibrillation lead connects to an implantable defibrillator. It...

    Anumana secures FDA clearance for ECG-AI algorithm

    Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an AI-enabled...

    M&A

    Archives

    Latest articles